NEULASTA for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where NEULASTA was used for Lung neoplasm malignant.
Most Reported Side Effects for NEULASTA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 453 | 30.8% | 453 | 16 |
| Investigation | 371 | 25.2% | 4 | 371 |
| Hospitalisation | 160 | 10.9% | 2 | 160 |
| Febrile neutropenia | 59 | 4.0% | 3 | 42 |
| Bone pain | 53 | 3.6% | 0 | 10 |
| Pyrexia | 40 | 2.7% | 1 | 32 |
| Pain | 29 | 2.0% | 1 | 10 |
| Neutrophil count abnormal | 28 | 1.9% | 1 | 20 |
| Malaise | 25 | 1.7% | 0 | 19 |
| Neutropenia | 24 | 1.6% | 2 | 7 |
| Drug ineffective | 22 | 1.5% | 2 | 11 |
| Dyspnoea | 21 | 1.4% | 4 | 10 |
| Pneumonia | 21 | 1.4% | 6 | 15 |
| Nausea | 20 | 1.4% | 1 | 13 |
| Arthralgia | 18 | 1.2% | 0 | 8 |
Other Indications for NEULASTA
Prophylaxis (1,012)
Product used for unknown indication (296)
Neutropenia (66)
Breast cancer (18)
Chemotherapy (16)
White blood cell count decreased (9)
B-cell lymphoma (7)
Chronic lymphocytic leukaemia (5)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)